Tip Sheet: Johns Hopkins Researchers Present at Annual CROI Meeting

Date: 03/01/2018

A5279 and P1078 are referenced in this press release from Johns Hopkins Medicine.

Study of MDR TB Cases and Their Household Contacts: Operational Feasibility to Inform PHOENIx Trial Design

Rationale: There is an urgent need for a platform to rapidly evaluate therapies in the outpatient setting, to prevent disease...

The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...

1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...

HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...